nnz2566
Small moleculeexperimental
Clinical trial activity
8 trials · 28 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT00961779)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nnz2566
- nnz 2566
- nnz-2566
- nnz-2566
- nnz-2566
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02715115 | Phase 2 | Mar 1, 2016 | Baylor University, Gillette Children's Specialty Healthcare, Greenwood Genetic Center, Harvard University, Neuren Pharmaceuticals Limited, Rett Syndrome Research Trust, Rush University, University of Alabama, Birmingham, University of California, San Diego, University of California, San Francisco, University of Cincinnati, University of Colorado, University of Pennsylvania, Vanderbilt University |
| NCT02100150 | Phase 2 | Sep 1, 2014 | Detroit Receiving Hospital, Neuren Pharmaceuticals Limited, United States Army, University of Arizona |
| NCT01894958 | Phase 2 | Jan 1, 2014 | Baylor University, Emory University, Geisinger Clinic, Greenwood Genetic Center, Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Icahn School of Medicine at Mount Sinai, Neuren Pharmaceuticals Limited, Rush University, University of California, Davis, University of Cincinnati, University of Colorado, University of Massachusetts, University of Michigan, University of Nebraska, University of Washington, Vanderbilt University |
| NCT01703533 | Phase 2 | Mar 1, 2013 | Baylor University, Gillette Children's Specialty Healthcare, International Rett Syndrome Foundation, Neuren Pharmaceuticals Limited, University of Alabama, Birmingham |
| NCT01366820 | Phase 2 | Feb 1, 2013 | Neuren Pharmaceuticals Limited, University of Miami |
| NCT01420042 | Phase 1 | Feb 1, 2012 | Neuren Pharmaceuticals Limited |
| NCT00805818 | Phase 2 | Apr 1, 2010 | Neuren Pharmaceuticals Limited, University of Miami |
| NCT00961779 | Phase 1 | Mar 1, 2010 | Neuren Pharmaceuticals Limited |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (28)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neuren Pharmaceuticals Limited | For profit | 8 | 8 | 2 | 2010 |
| Baylor University | Academic/Hospital | 3 | 0 | 1 | 2013 |
| Gillette Children's Specialty Healthcare | Academic/Hospital | 2 | 0 | 1 | 2013 |
| Greenwood Genetic Center | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Rush University | Academic/Hospital | 2 | 0 | 1 | 2014 |
| University of Alabama, Birmingham | Academic/Hospital | 2 | 0 | 1 | 2013 |
| University of Cincinnati | Academic/Hospital | 2 | 0 | 1 | 2014 |
| University of Colorado | Academic/Hospital | 2 | 0 | 1 | 2014 |
| University of Miami | Academic/Hospital | 2 | 0 | 1 | 2010 |
| Vanderbilt University | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Detroit Receiving Hospital | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Geisinger Clinic | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2014 |
| International Rett Syndrome Foundation | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Rett Syndrome Research Trust | Academic/Hospital | 1 | 0 | 1 | 2016 |
| United States Army | Government | 1 | 0 | 1 | 2014 |
| University of Arizona | Academic/Hospital | 1 | 0 | 1 | 2014 |
28 organizations
Page 1 / 2